Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Express Scripts
Dow
Johnson and Johnson
Baxter

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020637

See Plans and Pricing

« Back to Dashboard

NDA 020637 describes GLIADEL, which is a drug marketed by Arbor Pharms Llc and is included in one NDA. It is available from one supplier. Additional details are available on the GLIADEL profile page.

The generic ingredient in GLIADEL is carmustine. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the carmustine profile page.
Summary for 020637
Tradename:GLIADEL
Applicant:Arbor Pharms Llc
Ingredient:carmustine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020637
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for 020637
Suppliers and Packaging for NDA: 020637
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLIADEL carmustine IMPLANT;INTRACRANIAL 020637 NDA Arbor Pharmaceuticals 24338-050 24338-050-08 8 POUCH in 1 BOX (24338-050-08) > 1 WAFER in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:IMPLANT;INTRACRANIALStrength7.7MG
Approval Date:Sep 23, 1996TE:RLD:Yes

Expired US Patents for NDA 020637

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Arbor Pharms Llc GLIADEL carmustine IMPLANT;INTRACRANIAL 020637-001 Sep 23, 1996   Start Trial   Start Trial
Arbor Pharms Llc GLIADEL carmustine IMPLANT;INTRACRANIAL 020637-001 Sep 23, 1996   Start Trial   Start Trial
Arbor Pharms Llc GLIADEL carmustine IMPLANT;INTRACRANIAL 020637-001 Sep 23, 1996   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
Dow
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.